ArticleBMC nephrology2019

Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study.

Jiang Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.